Drugs / Fluzone® Quadrivalent Influenza Virus Vaccine, No Preservative
Fluzone® Quadrivalent Influenza Virus Vaccine, No Preservative
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01946425 | Sep → Dec 2013 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone Quadrivalent Influenza Virus Vaccine, No Preservative | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01946425 ↗ |
| Modality | Vaccine | “Fluzone® Quadrivalent Influenza Virus Vaccine” NCT01946425 ↗ |
| Route | Intramuscular | “Intramuscular” NCT01946425 ↗ |